Janux Therapeutics Inc (JANX)
29.62 x 1 49.32 x 2
Pre-market by (Cboe BZX)
30.83 -0.91 (-2.87%) 03/25/25 [NASDAQ]
29.62 x 1 49.32 x 2
Pre-market 30.51 -0.32 (-1.04%) 05:02 ET
for Tue, Mar 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,994 | -48,778 | -20,719 | -14,760 | -58,293 |
| Depreciation Amortization | -8,525 | -6,110 | -3,722 | -1,255 | -5,733 |
| Accounts receivable | N/A | N/A | -7,500 | -519 | N/A |
| Accounts payable and accrued liabilities | 1,584 | 25 | -1,150 | -456 | 277 |
| Other Working Capital | 685 | 1,030 | -11,799 | -4,447 | -6,554 |
| Other Operating Activity | 31,436 | 26,744 | 20,032 | 6,600 | 19,728 |
| Operating Cash Flow | $-43,814 | $-27,089 | $-24,858 | $-14,837 | $-50,575 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -257,662 | -291,630 | -304,329 | -113,539 | -39,344 |
| PPE Investments | -359 | -317 | -292 | -197 | -1,850 |
| Investing Cash Flow | $-258,021 | $-291,947 | $-304,621 | $-113,736 | $-41,194 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 713,235 | 326,585 | 324,936 | 322,171 | 59,548 |
| Financing Cash Flow | $713,235 | $326,585 | $324,936 | $322,171 | $59,548 |
| Beginning Cash Position | 20,021 | 20,021 | 20,021 | 20,021 | 52,242 |
| End Cash Position | 431,421 | 27,570 | 15,478 | 213,619 | 20,021 |
| Net Cash Flow | $411,400 | $7,549 | $-4,543 | $193,598 | $-32,221 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,814 | -27,089 | -24,858 | -14,837 | -50,575 |
| Capital Expenditure | -359 | -317 | -292 | -197 | -1,850 |
| Free Cash Flow | -44,173 | -27,406 | -25,150 | -15,034 | -52,425 |